E-mail ID : info@iamg.in |
Online Submission |
Click Here For Online Submission |
Instructions for authors |
Genetic Clinics |
Editorial board |
Get Our Newsletter |
Subscribe |
Send Your Feedback |
Feedback Form |
About Us |
IAMG |
Abstract
January to March 2020 | Vol. 13 | Issue 1 | 06-10 | |||
Antisense Oligonucleotides: Adding Sense to Therapeutic Medicine | |||
A Haseena, Amita Moirangthem, Shubha R Phadke | |||
Department of Medical Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India | |||
Address for Correspondence Email: amis.72000@gmail.com | |||
Abstract Rapid progress in the field of molecular biology has led to the development of numerous genetic therapies. Among these, antisense oligonucleotide (ASO) therapeutics have recently gained momentum due to their application in the spectrum of disorders ranging from neurodegenerative disorders to malignancies. This brief review discusses the principle of ASO based therapies, mechanism of action and their current role in the field of therapeutic medicine. | |||
HTML Full Text | Download PDF |